cP12
Phase 2Recruiting 0 views this week 0 watching💤 Quiet
Interest: 39/100
39
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Thermal Burns
Conditions
Thermal Burns
Trial Timeline
May 12, 2025 → Nov 1, 2026
NCT ID
NCT06814717About cP12
cP12 is a phase 2 stage product being developed by United Therapeutics for Thermal Burns. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06814717. Target conditions include Thermal Burns.
What happened to similar drugs?
0 of 2 similar drugs in Thermal Burns were approved
Approved (0) Terminated (0) Active (2)
Hype Score Breakdown
Clinical
12
Activity
15
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06814717 | Phase 2 | Recruiting |
Competing Products
4 competing products in Thermal Burns
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| R475 + Placebo | Sanofi | Phase 2 | 27 |
| NexoBrid | MediWound | Pre-clinical | 16 |
| NexoBrid + Gel Vehicle | MediWound | Phase 3 | 30 |
| NexoBrid | MediWound | Phase 3 | 30 |